Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CSF dopamine beta-hydroxylase in schizophrenia.

D E Sternberg, D P van Kammen, P Lerner

    Archives of General Psychiatry
    |July 1, 1983
    PubMed
    Summary

    Low dopamine beta-hydroxylase (DBH) activity in cerebrospinal fluid (CSF) may indicate a subgroup of schizophrenia patients with a better prognosis and treatment response. This finding suggests DBH levels could predict clinical course and treatment effectiveness.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    From the benches to the trenches : training residents to provide emergency outreach services-a public/academic project.

    Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry·2014
    Same author

    Adolescents' response to nuclear threat: Before and after the chernobyl accident.

    Journal of youth and adolescence·2013
    Same author

    Vagus nerve stimulation: a new form of therapeutic brain stimulation.

    CNS spectrums·2008
    Same author

    Membrane polyunsaturated fatty acids and CSF cytokines in patients with schizophrenia.

    Prostaglandins, leukotrienes, and essential fatty acids·2003
    Same author

    Consensus statement on depression, anxiety, and cardiovascular disease.

    The Journal of clinical psychiatry·2002
    Same author

    Consensus statement on depression, anxiety, and functional gastrointestinal disorders.

    The Journal of clinical psychiatry·2002

    Area of Science:

    • Neuroscience
    • Biochemistry
    • Psychiatry

    Background:

    • Dopamine beta-hydroxylase (DBH) is crucial for converting dopamine to norepinephrine.
    • Investigating DBH activity in cerebrospinal fluid (CSF) may offer insights into schizophrenia pathophysiology.
    • Previous research has not definitively linked CSF DBH levels to schizophrenia subtypes or treatment response.

    Purpose of the Study:

    • To measure and compare CSF DBH activity in schizophrenic patients and healthy controls.
    • To examine the relationship between CSF DBH levels and clinical characteristics, including functioning, prognosis, and neuroleptic treatment response in schizophrenia.
    • To explore the potential of CSF DBH as a biomarker for a specific schizophrenia subgroup.

    Main Methods:

    • CSF samples were collected from 30 patients diagnosed with schizophrenia and 27 healthy controls.

    Related Experiment Videos

  • DBH enzyme activity was quantified in all CSF samples.
  • Correlations were analyzed between CSF DBH levels and clinical variables such as social/sexual functioning, prognosis, symptom severity, and neuroleptic response.

    • Main Results:

    • No significant difference in mean CSF DBH activity was found between schizophrenic patients and controls.
    • CSF DBH activity remained stable over time and was unaffected by clinical status or medication.
    • Lower CSF DBH levels were significantly associated with better social and sexual functioning, a better prognosis, fewer inter-hospitalization symptoms, and an excellent response to neuroleptic treatment.

    Conclusions:

    • Low CSF DBH activity may identify a subgroup of schizophrenia patients characterized by a more "reactive" profile.
    • This subgroup may exhibit better clinical outcomes and a more favorable response to neuroleptic therapies.
    • While not causative, low brain DBH activity might contribute to vulnerability to psychotic decompensation and influence the schizophrenia disease course.